Objective: To characterize the subtype C strains of HIV type I that circulate in Brazil, especially those originated from the southern part of the country.Design and methods: One hundred and twelve HIV-1-positive subjects had their plasma viral RNA extracted. Protease (PR) and reverse transcriptase (RT) genomic regions were polymerase chain reaction-amplified and sequenced for subtype determination. Subtype C strains were selected and compared to other strains of this subtype from the database, and specific amino acid signature patterns were searched.Results: Brazilian subtype C viruses form a very strong monophyletic group when compared to subtype C viruses from other countries and presented specific signature amino acids. Recombinants bet...
The extraordinary genetic diversity and immune evasion of human immunodeficiency virus (HIV) pose si...
In order to assess the human immunodeficiency virus type 1 (HIV-1) drug resistance mutation profiles...
In order to assess the human immunodeficiency virus type 1 (HIV-1) drug resistance mutation profiles...
Objectives: To describe the molecular and epidemiological profile of HIV-1 in patients followed at ...
Objective: To identify a new circulating recombinant form (CRF) of HIV-1 comprising two circulating...
Objectives: To describe the molecular and epidemiological profile of HIV-1 in patients followed at t...
Design and methods: A cross-sectional study was conducted from September to December 2002. Plasma vi...
The molecular and biological properties of HIV-1 subtype C strains from South Brazil were investigat...
Background: Rio Grande do Sul, the southernmost state of Brazil, presents an atypical epidemiologica...
Background: Rio Grande do Sul, the southernmost state of Brazil, presents an atypical epidemiologica...
Background: Rio Grande do Sul, the southernmost state of Brazil, presents an atypical epidemiologica...
In order to assess the human immunodeficiency virus type 1 (HIV-1) drug resistance mutation profiles...
In order to assess the human immunodeficiency virus type 1 (HIV-1) drug resistance mutation profiles...
The most prevalent HIV-1 clade in the global epidemics is C, and this clade is also becoming importa...
The extraordinary genetic diversity and immune evasion of human immunodeficiency virus (HIV) pose si...
The extraordinary genetic diversity and immune evasion of human immunodeficiency virus (HIV) pose si...
In order to assess the human immunodeficiency virus type 1 (HIV-1) drug resistance mutation profiles...
In order to assess the human immunodeficiency virus type 1 (HIV-1) drug resistance mutation profiles...
Objectives: To describe the molecular and epidemiological profile of HIV-1 in patients followed at ...
Objective: To identify a new circulating recombinant form (CRF) of HIV-1 comprising two circulating...
Objectives: To describe the molecular and epidemiological profile of HIV-1 in patients followed at t...
Design and methods: A cross-sectional study was conducted from September to December 2002. Plasma vi...
The molecular and biological properties of HIV-1 subtype C strains from South Brazil were investigat...
Background: Rio Grande do Sul, the southernmost state of Brazil, presents an atypical epidemiologica...
Background: Rio Grande do Sul, the southernmost state of Brazil, presents an atypical epidemiologica...
Background: Rio Grande do Sul, the southernmost state of Brazil, presents an atypical epidemiologica...
In order to assess the human immunodeficiency virus type 1 (HIV-1) drug resistance mutation profiles...
In order to assess the human immunodeficiency virus type 1 (HIV-1) drug resistance mutation profiles...
The most prevalent HIV-1 clade in the global epidemics is C, and this clade is also becoming importa...
The extraordinary genetic diversity and immune evasion of human immunodeficiency virus (HIV) pose si...
The extraordinary genetic diversity and immune evasion of human immunodeficiency virus (HIV) pose si...
In order to assess the human immunodeficiency virus type 1 (HIV-1) drug resistance mutation profiles...
In order to assess the human immunodeficiency virus type 1 (HIV-1) drug resistance mutation profiles...